...
机译:多级疫苗候选(MTB8.4-Hspx和Hspx-MTB8.4)对小鼠结核分枝杆菌感染的免疫原性和保护效果
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Gansu Provincial Key Laboratory of Evidence Based Medicine and Clinical Translation &
Lanzhou;
Mycobacterium tuberculosis; Protein vaccine; Mtb8.4; HspX; Protein sequential order; Antigen dose;
机译:多级疫苗候选(MTB8.4-Hspx和Hspx-MTB8.4)对小鼠结核分枝杆菌感染的免疫原性和保护效果
机译:编码分枝杆菌热休克蛋白65(Hsp65)与人白介素2融合蛋白的DNA疫苗在BALB / c小鼠中的免疫原性和保护功效。
机译:MTBVAC疫苗是安全,具有免疫原性的疫苗,具有新生小鼠结核分枝杆菌的保护作用
机译:从结核分枝杆菌中表达AG85B和MPT83融合蛋白的新疫苗免疫原性和保护效果的研究
机译:在鼠模型中,使用天然减毒的分枝杆菌可降低减毒活疫苗抵抗结核分枝杆菌的保护功效的主要因素。
机译:of的免疫原性和体外保护作用。 重组多阶段恶性疟原虫 候选疫苗
机译:由抗原Ag85b和Hspx组成的融合蛋白疫苗的免疫原性和保护效果免受小鼠结核分枝杆菌感染的影响